Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Sequenom, Qiagen, Asuragen, Affymetrix, Johns Hopkins, Others Win US Patents


Vertex Pharmaceuticals has been awarded US Patent No. 8,679,740, "Methods for amplifying hepatitis C virus nucleic acids."

Ann Kwong, James Frantz, Douglas Bartels, Chao Lin, Benjamin Shames, Sheila Seepersaud, Judith Lippke, Tara Kieffer, Yi Zhou, Eileen Zhang, and James Sullivan are named as inventors.

Sequenom has been awarded US Patent No. 8,679,741, "Methods and compositions for the extraction and amplification of nucleic acid from a sample."

Carolyn Hoyal-Wrightson, Andreas Braun, and Karsten Schmidt are named as inventors.

Qiagen has been awarded US Patent No. 8,679,744, "Method for cleaning and isolating nucleic acid using ammonium or phosphonium cationic detergents."

Thorsten Singer is named as the inventor.

Epigenomics AG has been awarded US Patent No. 8,679,745, "Method for providing DNA fragments derived from an archived sample."

Matthias Ballhause, Kurt Berlin, Dimo Dietrich, Antje Lukas, Matthias Schuster, Ute Wagner, Reinhold Wasserkort, and Heike Ziebarth are named as inventors.

Infraegis has been awarded US Patent No. 8,679,752, "Compositions and methods for detecting food-borne pathogens."

Robert Levin is named as the inventor.

Asuragen has been awarded US Patent No. 8,679,757, "PCR methods for characterizing the 5' untranslated region of the FMR1 and FMR2 genes."

Gary Latham, Liangjing Chen, and Sachin Sah are named as inventors.

Affymetrix has been awarded US Patent No. 8,679,758, "Complexity management of genomic DNA."

Hajime Matsuzaki, Xing Su, Sean Walsh, Giulia Kennedy, and Rui Mei are named as inventors.

The Johns Hopkins University has been awarded US Patent No. 8,679,788, "Methods for the detection of nucleic acid differences."

James Eshleman, Chanjuan Shi, and Susan Eshleman are named as inventors.

The Chinese University of Hong Kong has been awarded US Patent No. 8,680,255, "Detection of HBX/8P11 hybrid sequence in human hepatocellular carcinoma."

Nathalie Wong is named as the inventor.

US Patent No. 8,680,257, "Kits for comparative transcript analysis and mutant sequence enrichment," has been awarded to an unspecified entity.

Ming-Sheng Lee, Chung-Han Lee, and Jeffery Lee are named as inventors.

US Patent No. 8,680,261, "Methods for purifying nucleic acids," has been awarded to an unspecified entity.

Robert Bridenbaugh, Warren Dang, and Lee Bussey are named as inventors.

Natera has been awarded US Patent No. 8,682,592, "System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals."

Matthew Rabinowitz, Milena Banjevic, Zachary Demko, and David Johnson are named as inventors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.